Do we need a revision of current recommendations for breast cancer screening? According to a recent prospective multicenter cohort study published in the “Journal of Clinical Oncology”, this appears advisable at least for young women carrying an increased risk of breast cancer.
Here is the original:
Breast Cancer Screening: No Added Value Through Mammography (Medical News Today)
Do we need a revision of current recommendations for breast cancer screening? According to a recent prospective multicenter cohort study published in the “Journal of Clinical Oncology”, this appears advisable at least for young women carrying an increased risk of breast cancer.
See more here:
Breast cancer screening: No added value through mammography (PhysOrg)
Contralateral prophylactic mastectomy (CPM), a preventive procedure to remove the unaffected breast in patients with disease in one breast, may only offer a survival benefit to breast cancer patients age 50 and younger, who have early-stage disease and are estrogen receptor (ER) negative, according to researchers at The University of Texas M. D
See the original post here:
Contralateral Prophylactic Mastectomy Associated With Survival In Select Group Of Breast Cancer Patients (Medical News Today)
Do we need a revision of current recommendations for breast cancer screening? According to a recent prospective multicenter cohort study published in the Journal of Clinical Oncology, this appears advisable at least for young women carrying an increased risk of breast cancer.
More:
Breast cancer screening: No added value through mammography (EurekAlert!)
Do we need a revision of current recommendations for breast cancer screening?
